---
$id: https://graph.org.ai/products/commodity/51152022
$type: Product
source: UNSPSC
code: "51152022"
title: "Cyclobenzaprine"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cyclobenzaprine

**UNSPSC Code**: 51152022
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C20H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 69O5WQQ5TI, chemically known as 10,11-dehydroamitriptyline but generally known as cyclobenzaprine, which bears US NIH Compound Identifier 2895. European Medicines Agency schedules Cyclobenzaprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06849MIG. The term CYCLOBENZAPRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules cyclobenzaprine in its Anatomical Therapeutic Chemical (ATC) Classification. CYCLOBENZAPRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyclobenzaprine under HS 29214980 and SITC 51454. As of Q4 2014, CYCLOBENZAPRINE remains the US FDA Preferred Term for this commodity. Cyclobenzaprine bears US NLM identifiers UMLS ID C0056732 and NCI Concept Code C28947. SMILES: N(CC/C=C1\C2C(C=CC3C1CCCC3)CCCC2)(C)C.

